Junzhuan Qiu

Title: Junzhuan Qiu: Innovator in Cancer Treatment

Introduction

Junzhuan Qiu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative treatments for cancer. His work focuses on the creation of antibodies that target specific cancer cells, enhancing the efficacy of therapeutic interventions.

Latest Patents

Junzhuan Qiu holds a patent for an "Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereof." This patent describes an anti-c-Met antibody or an antigen binding fragment, which can be a chimeric or humanized antibody. The invention also includes pharmaceutical compositions that utilize the humanized anti-c-Met antibody or its fragments, aimed at treating cancer effectively.

Career Highlights

Throughout his career, Junzhuan Qiu has worked with notable companies in the biopharmaceutical sector. He has been associated with Suzhou Suncadia Biopharmaceuticals Co., Ltd. and Jiangsu Hengrui Medicine Company Ltd. His experience in these organizations has contributed to his expertise in developing innovative cancer therapies.

Collaborations

Junzhuan Qiu has collaborated with esteemed colleagues in his field, including Jiajian Liu and Lianshan Zhang. These partnerships have fostered a collaborative environment that enhances research and development efforts in cancer treatment.

Conclusion

Junzhuan Qiu is a key figure in the advancement of cancer therapies through his innovative patents and collaborations. His work continues to impact the biopharmaceutical industry positively, paving the way for new treatment options for patients.